Targeting Inflammation for Endometrial Cancer Prevention

Active, not recruitingOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Endometrial Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood, urine, and tissue samples

OTHER

Questionnaire Administration

Complete risk factor questionnaire

Trial Locations (2)

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05407025 - Targeting Inflammation for Endometrial Cancer Prevention | Biotech Hunter | Biotech Hunter